> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears Elekta’s Venezia Applicator for Cervical Cancer
- URL: https://www.fdaweb.com/fda-clears-elektas-venezia-applicator-for-cervical-cancer/
- Published: 2017-02-06T12:00:00.000Z
- Updated: 2026-09-14T22:04:53.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5137913

FDA has cleared an Elekta 510(k) for its Venezia applicator for gynecological brachytherapy in treating advanced-stage cervical cancer. Venezia received CE Mark approval in November 2016\. “There is overwhelming clinical evidence that modern image-guided brachytherapy is an effective treatment modality for cervical cancer,” the company says. “Advanced stage disease, however, often requires an interstitial technique due to a less than complete response to chemoradiation therapy.” Modified intracavitary applicators, like Venezia, allow better interstitial coverage and require less technical skill and training, it says.